Scott Hutton - 08 Feb 2022 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
President & CEO, Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton
Issuer symbol
BDSX
Transactions as of
08 Feb 2022
Net transactions value
$0
Form type
4
Filing time
10 Feb 2022, 18:08:56 UTC
Previous filing
18 Nov 2021
Next filing
11 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +195,392 $0.000000 195,392 08 Feb 2022 Common Stock 195,392 Direct F1, F2
transaction BDSX Restricted Stock Units Award $0 +195,393 $0.000000 195,393 08 Feb 2022 Common Stock 195,393 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
F3 These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.